Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study

BACKGROUND: Patients with diabetic cardiomyopathy have an impaired myocardial glucose handling and distal distribution of coronary atherosclerosis. Trimetazidine, an anti-ischemic metabolic agent, improves myocardial glucose utilization though inhibition of fatty acid oxidation. Aim of the present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosano, Giuseppe MC, Vitale, Cristiana, Sposato, Barbara, Mercuro, Giuseppe, Fini, Massimo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305354/
https://www.ncbi.nlm.nih.gov/pubmed/14641923
http://dx.doi.org/10.1186/1475-2840-2-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305354/
https://www.ncbi.nlm.nih.gov/pubmed/14641923
http://dx.doi.org/10.1186/1475-2840-2-16

Ejemplares similares